A lightweight portable oxygen concentrator (POC) that helps give you the confidence to manage your condition.
Easy to read and use LCD touchscreen, with five pulse dose settings
Lightweight and easy-to-carry
Rugged constructioncombines with elegant design for reliability and confidence
Simple to replace rechargeable batterythat lasts up to 4.5 hours (up to 9 hours with extended battery)**
*RTCA/DO-160G section 21, category M
**Battery duration times are based on new, fully charged batteries used with a new SimplyGo Mini system. Battery duration times will degrade with battery age, environmental operating conditions, use over time, and operational condition of the concentrator.
SimplyGo Mini is a breakthrough in lightweight portable oxygen therapy.
SimplyGo Mini’s reliable performance and stylish look could be just what you need to get back to living life your way, with confidence.
Living and competing with COPD
Setting goals is important in a COPD journey. For Russell Winwood, this meant tackling the marathon in Boston. Watch his story.
Get 15% off your next purchase*. Sign up today for offers, news and product updates.
COPD is estimated to affect more than 210 million people worldwide1 as the fourth leading cause of death, and is becoming more prevalent every day2. But through education, engagement, and empowerment we can help those affected by the disease live a fulfilling life.
Learn more about World COPD Day and how you can help support the COPD Foundation with a donation from Philips.
COPD is a term that covers a number of progressive lung conditions that make breathing difficult, including chronic bronchitis and emphysema¹. One of the main causes is prolonged exposure to cigarette smoke, especially if the smoke is inhaled. However, breathing in second hand smoke, air pollution, chemical fumes and dust from the environment or workplace can also cause COPD².
A chronic cough, one that lasts for several weeks without the presence of other illness such as cold or flu, is the first sign of COPD. The cough is usually worse early in the morning, and may be aggravated by exercise or smoke. Other typical symptoms include shortness of breath, wheezing, tightness in the chest and increased mucus (or phlegm) production 1,2.
One of the main causes of COPD is prolonged exposure to cigarette smoke, especially if the smoke is inhaled. But breathing in secondhand smoke, air pollution, chemical fumes or dust from the workplace also can cause the condition1.
These inhaled particles can cause the mucus glands that line the bronchi to produce more mucus than normal. In addition, the inflammation that they trigger causes the walls of the bronchi to thicken and swell. Environmental factors and genetics may also play a part in the development of COPD 1,2.
COPD has four stages, each one with different symptoms of increasing severity. However, by monitoring your symptoms and effectively managing them, it is possible to slow the progression of the disease and to enjoy a more active life1,2.
Combining a program of exercise, education and support, pulmonary rehab can help you live more comfortably with COPD by increasing your capacity for exercise and improving your mobility. You’ll learn about effective breathing techniques, relaxation exercises, the use of medication and oxygen, good nutrition and travel tips, as well as how to avoid flare-ups and stay healthy. Pulmonary rehab also provides an opportunity meet others with COPD to exchange experiences, provide mutual encouragement and increase determination to improve fitness levels and fight the disease1.
Genetics can play a part in the development of COPD, even if you have never smoked or been exposed to pollutants for an extended period of time. In particular, emphysema can be triggered by a deficiency in alpha-1 antitrypsin (AAT), which is a protein that protects the lungs from the harmful effects of white blood cells in the lungs. However, not everyone with COPD who has never smoked has a deficiency on AAT, so it is believed that there must be other genetic triggers for COPD1.
2Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380(9859): 2095-128.
By clicking on the link, you will be leaving the official Royal Philips ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.